单位(元)天弘国证生物医药ETF(159859)资产负债表 |
| 报告期 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
2021/12/31 |
| 资产 |
| 银行存款 |
5,592,689 |
5,476,275 |
5,008,017 |
4,991,344 |
| 结算备付金 |
2,100,573 |
717,037 |
323,815 |
2,035,595 |
| 存出保证金 |
1,698,544 |
1,075,140 |
847,484 |
1,001,862 |
| 交易性金融资产 |
2,915,080,149 |
1,473,576,457 |
1,246,753,920 |
1,195,864,178 |
| 其中：股票投资 |
2,915,080,149 |
1,473,576,457 |
1,246,753,920 |
1,195,864,178 |
| 基金投资 |
- |
- |
- |
- |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
125,733 |
6,554,019 |
227,561 |
2,148,579 |
| 应收利息 |
- |
- |
- |
12,756 |
| 应收股利 |
10,218 |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
92,003 |
76,735 |
163,732 |
- |
| 资产总计 |
2,924,699,909 |
1,487,475,663 |
1,253,324,530 |
1,206,054,314 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
3,056,025 |
8,905,312 |
5,622,157 |
2,434,576 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
1,172,768 |
635,384 |
441,326 |
451,523 |
| 应付托管费 |
234,554 |
127,077 |
88,265 |
90,305 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
166,087 |
| 应交税费 |
11,036 |
2,630 |
3,069 |
268 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
444,616 |
494,173 |
260,070 |
69,753 |
| 负债合计 |
4,918,999 |
10,164,576 |
6,414,887 |
3,212,512 |
| 所有者权益 |
| 实收基金 |
6,275,240,054 |
2,491,640,054 |
1,753,640,054 |
1,469,240,054 |
| 未分配利润 |
-3,355,459,145 |
-1,014,328,967 |
-506,730,411 |
-266,398,252 |
| 所有者权益合计 |
2,919,780,909 |
1,477,311,087 |
1,246,909,643 |
1,202,841,802 |
| 负债和所有者权益总计 |
2,924,699,909 |
1,487,475,663 |
1,253,324,530 |
1,206,054,314 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
